Summary

Eligibility
for people ages 18-60 (full criteria)
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Sachin Allahabadi, MD

Description

Summary

The purpose of this study is to evaluate post-operative outcomes after meniscus surgery in participants undergoing blood flow restriction training as a rehabilitative adjunct compared to those with standard rehabilitation.

Official Title

Outcomes of Blood Flow Restriction Training in Post-operative Rehabilitation After Meniscus Repair Surgery

Details

The investigators will conduct a double-blinded, single-institution, randomized controlled trial to compare patients undergoing arthroscopic meniscus repair with post-operative rehabilitation protocol as (1) a standard-of-care rehabilitative protocol with a non-occlusive blood pressure cuff (inflated to 20-30 mm Hg) applied to the operative extremity versus (2) blood flow restriction training with cuff occlusion applied to the operative extremity. Patients will be enrolled prospectively and pre-operatively at their initial clinic visit after meniscus injury.

Rehabilitative exercises would be advanced per the physical therapists' discretion with similar exercises for patients in both groups for direct comparison. These exercises are part of an already-established post-operative protocol that is in place, with the only difference being the addition of the blood flow restriction protocol in the intervention group. All patients would undergo their supervised post-operative rehabilitation at our institution.

Keywords

Meniscus Disorder, Meniscus, Torn Tibial, Meniscus Lesion, Meniscus Tear, Tibial, Atrophy, Muscular, blood flow restriction, rehabilitation, meniscus repair, Muscular Atrophy, Tibial Meniscus Injuries, Blood flow restriction (Delfi Personalized Tourniquet System)

Eligibility

You can join if…

Open to people ages 18-60

  • Participants who undergo surgery for arthroscopic meniscus repair

You CAN'T join if...

Location

  • UCSF accepting new patients
    San Francisco California 94158 United States

Lead Scientist at UCSF

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT04436523
Study Type
Interventional
Participants
Expecting 70 study participants
Last Updated